Cargando…

Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington’s disease subjects

Huntington’s disease (HD) is a severe neurological disease leading to psychiatric symptoms, motor impairment and cognitive decline. The disease is caused by a CAG expansion in the huntingtin (HTT) gene, but how this translates into the clinical phenotype of HD remains elusive. Using liquid chromatog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herman, Stephanie, Niemelä, Valter, Emami Khoonsari, Payam, Sundblom, Jimmy, Burman, Joachim, Landtblom, Anne-Marie, Spjuth, Ola, Nyholm, Dag, Kultima, Kim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411723/ https://www.ncbi.nlm.nih.gov/pubmed/30858393 http://dx.doi.org/10.1038/s41598-019-40186-5

Ejemplares similares

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
por: Niemela, Valter, et al.
Publicado: (2020)

Tau or neurofilament light—Which is the more suitable biomarker for Huntington’s disease?
por: Niemelä, Valter, et al.
Publicado: (2017)

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease
por: Niemelä, Valter, et al.
Publicado: (2018)

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
por: Herman, Stephanie, et al.
Publicado: (2019)

Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid
por: Peters, Kristian, et al.
Publicado: (2021)

Container-based bioinformatics with Pachyderm
por: Novella, Jon Ander, et al.
Publicado: (2019)

Disease phenotype prediction in multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2023)

Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2018)

Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions
por: Herman, Stephanie, et al.
Publicado: (2017)

Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
por: Carlsson, Henrik, et al.
Publicado: (2020)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
por: Braun, Madelene, et al.
Publicado: (2023)

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
por: Vaivade, Aina, et al.
Publicado: (2023)

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
por: Khoonsari, Payam Emami, et al.
Publicado: (2019)

Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures
por: Nikitidou, Elisabeth, et al.
Publicado: (2017)

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
por: Carlsson, Henrik, et al.
Publicado: (2021)

Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
por: Braun, Madelene, et al.
Publicado: (2022)

Integration of small RNAs from plasma and cerebrospinal fluid for classification of multiple sclerosis
por: Needhamsen, Maria, et al.
Publicado: (2022)

Psychosis in Patients with Narcolepsy as an Adverse Effect of Sodium Oxybate
por: Sarkanen, Tomi, et al.
Publicado: (2014)

Adaptation of Phenylalanine and Tyrosine Catabolic Pathway to Hibernation in Bats
por: Pan, Yi-Hsuan, et al.
Publicado: (2013)

Phenylalanine and Tyrosine Kinetics in Critically Ill Children with Sepsis
por: Castillo, Leticia, et al.
Publicado: (1994)

Identification of the Tyrosine- and Phenylalanine-Derived Soluble Metabolomes of Sorghum
por: Simpson, Jeffrey P., et al.
Publicado: (2021)

The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023)

High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study
por: Sundblom, Jimmy, et al.
Publicado: (2020)

Development and Testing of Force Field Parameters for Phenylalanine and Tyrosine Derivatives
por: Wang, Xiaowen, et al.
Publicado: (2020)

Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine
por: Kun, Szilárd, et al.
Publicado: (2015)

Engineered Escherichia coli platforms for tyrosine-derivative production from phenylalanine using phenylalanine hydroxylase and tetrahydrobiopterin-regeneration system
por: Satoh, Yasuharu, et al.
Publicado: (2023)

No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder
por: Bergwerff, Catharina Elisabeth, et al.
Publicado: (2016)

Dried blood spot versus venous blood sampling for phenylalanine and tyrosine
por: van Vliet, Kimber, et al.
Publicado: (2020)

Aggravated hepatic fibrosis induced by phenylalanine and tyrosine was ameliorated by chitooligosaccharides supplementation
por: Liu, Peng, et al.
Publicado: (2023)

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
por: Byrne, Lauren M., et al.
Publicado: (2018)

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria
por: Hughes, Juliette H., et al.
Publicado: (2020)

Synthesis of Isotopically Labeled, Spin-Isolated Tyrosine and Phenylalanine for Protein NMR Applications
por: Young, Brandon M., et al.
Publicado: (2021)

Translational incorporation of modified phenylalanines and tyrosines during cell-free protein synthesis
por: Wang, Zhongqiang, et al.
Publicado: (2020)

Metabolomics and Network Analyses Reveal Phenylalanine and Tyrosine as Signatures of Anthracycline-Induced Hepatotoxicity
por: Liu, Peipei, et al.
Publicado: (2023)

Efficient biosynthesis of resveratrol via combining phenylalanine and tyrosine pathways in Saccharomyces cerevisiae
por: Meng, Lijun, et al.
Publicado: (2023)

Specificity of the Acute Tryptophan and Tyrosine Plus Phenylalanine Depletion and Loading Tests Part II: Normalisation of the Tryptophan and the Tyrosine Plus Phenylalanine to Competing Amino Acid Ratios in a New Control Formulation
por: Badawy, Abdulla A.-B., et al.
Publicado: (2010)

Predicting protein network topology clusters from chemical structure using deep learning
por: Sreenivasan, Akshai P., et al.
Publicado: (2022)

Specificity of the Acute Tryptophan and Tyrosine Plus Phenylalanine Depletion and Loading Tests I. Review of Biochemical Aspects and Poor Specificity of Current Amino Acid Formulations
por: Badawy, Abdulla A.-B., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1jlri67t2jpi99efjn7ahiql04